CENTERSPACE (CSR) capitalization

Current snapshot

Market Cap
$965.3M
16.8M shares × $57.45 · as of last filing 2026-03-31
Net Worth
$695.0M
Stockholders' equity · 2026-03-31
Enterprise Value
$1.97B
Market cap + debt − cash
Net Debt
$1.01B
Debt $1.02B − Cash $7.6M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $1.12B
FY'24 2024-12-31 $1.03B
FY'23 2023-12-31 $996.3M
FY'22 2022-12-31 $892.7M
FY'21 2021-12-31 $1.53B
FY'20 2020-12-31 $887.5M
FY'19 2019-12-31 $955.7M
FY'20 2018-12-31 $653.8M
FY'18 2018-04-30 $71.7M
FY'17 2017-04-30 $81.1M
FY'16 2016-04-30 $827.0M
FY'15 2015-04-30 $965.1M
FY'14 2014-04-30 $1.11B
FY'13 2013-04-30 $1.11B
FY'12 2012-04-30 $746.8M
FY'11 2011-04-30
FY'11 2010-04-30
FY'11 2009-04-30

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $963.7M
Q4'25 2025-12-31
Q3'25 2025-09-30 $1.16B
Q2'25 2025-06-30 $1.01B
Q1'25 2025-03-31 $1.08B
Q4'24 2024-12-31
Q3'24 2024-09-30 $1.09B
Q2'24 2024-06-30 $1.01B
Q1'24 2024-03-31 $852.6M
Q4'23 2023-12-31
Q3'23 2023-09-30 $1.09B
Q2'23 2023-06-30 $917.3M
Q1'23 2023-03-31 $1.00B
Q4'22 2022-12-31
Q3'22 2022-09-30 $1.03B
Q2'22 2022-06-30 $1.25B
Q1'22 2022-03-31 $1.48B
Q4'21 2021-12-31
Q3'21 2021-09-30 $1.33B
Q2'21 2021-06-30 $1.15B
Q1'21 2021-03-31 $954.4M
Q4'20 2020-12-31
Q3'20 2020-09-30 $921.7M
Q2'20 2020-06-30 $938.7M
Q1'20 2020-03-31 $723.6M
Q4'19 2019-12-31
Q3'19 2019-09-30 $977.2M
Q2'19 2019-06-30 $760.1M
Q1'19 2019-03-31 $792.5M
Q4'20 2018-12-31
Q2'19 2018-10-31 $723.2M
Q3'19 2018-09-30 $79.6M
Q1'19 2018-07-31 $730.3M
Q2'19 2018-06-30 $73.7M
Q4'18 2018-04-30
Q1'19 2018-03-31 $69.5M
Q3'18 2018-01-31 $760.8M
Q1'19 2017-12-31
Q2'18 2017-10-31 $788.4M
Q1'18 2017-07-31 $843.1M
Q4'17 2017-04-30
Q3'17 2017-01-31 $884.7M
Q2'17 2016-10-31 $834.1M
Q1'17 2016-07-31 $909.6M
Q4'16 2016-04-30 $729.0M
Q3'16 2016-01-31 $885.0M
Q2'16 2015-10-31 $1.13B
Q1'16 2015-07-31 $1.00B
Q4'15 2015-04-30 $892.3M
Q3'15 2015-01-31 $1.12B
Q2'15 2014-10-31 $1.12B
Q1'15 2014-07-31 $1.12B
Q4'14 2014-04-30 $950.6M
Q3'14 2014-01-31 $1.11B
Q2'14 2013-10-31 $1.09B
Q1'14 2013-07-31 $1.07B
Q4'13 2013-04-30 $987.5M
Q3'13 2013-01-31 $1.08B
Q2'13 2012-10-31
Q1'13 2012-07-31 $908.1M
Q4'12 2012-04-30
Q3'12 2012-01-31 $771.2M
Q2'12 2011-10-31 $753.4M
Q1'12 2011-07-31
Q4'11 2011-04-30
Q3'12 2011-01-31
Q2'12 2010-10-31
Q1'12 2010-07-31
Q4'11 2010-04-30

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (CSR CIK 0000798359), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

NKE

NIKE, Inc.

VTVT

vTv Therapeutics Inc.

DYAI

DYADIC INTERNATIONAL, INC.